{"disease":{"id":"sintilimab-and-anlotinib-in-combination-with-chemotherapy","name":"sintilimab and anlotinib in combination with chemotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06015035","title":"Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Tang-Du Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}